The Biopharmaceuticals MSc is an advanced study programme that will provide chemical, life science and pharmacy graduates with the scientific knowledge and expertise in the areas of biopharmaceutical discovery and development needed for careers in the pharmaceutical and biotech industry, research institutes or regulatory authorities.
This course was designed to address the growing needs of the Biotech industry. The Biopharmaceuticals MSc course is an interdisciplinary course of study with the aim of developing medicines for the future. The subject areas will include drug delivery & disposition and pharmaceuticals analysis followed by more specialised studies on the discovery of peptides, proteins and antibody therapeutics and their development into medicines.
An integral component of the course is a laboratory research dissertation worth 60 credits where you will work in a research laboratory involved with independent research supervised by experts in the field.
Teaching
We use lectures, seminars and group tutorials to deliver most of the modules on the programme. You will also be expected to undertake a significant amount of independent study.
Assessment
You are assessed through a combination of the following methods:
Production of research paper (50%)
The study time and assessment methods detailed above are typical and give you a good indication of what to expect.
Regulating body
King’s College London is regulated by the Higher Education Funding Council for England.
Recent graduates have gone on to work in research and development laboratories in the Pharmaceutical and Biopharmaceutical Industries. Employers include Pfizer, GSK and Novartis and small Biotech companies. Overseas students have returned to similar positions in their home countries. Other graduates choose to continue to study towards a PhD.
The Oncology Drug Discovery MSc course is designed to provide an insight into how existing and future drug targets are identified from biological samples isolated from the cancer clinic. This will include an industrial viewpoint into what makes an interesting target and how, through an iterative process, this target is validated. In addition, lectures will be provided to discuss how ‘hit’ compounds are identified, in both the academic and industrial setting, using compound screen assays and fragment based screening technologies. We will also provide an insight in computational methods for generating chemical ‘hits’. The module will also cover how these ‘hit’ compounds are prosecuted into tool compounds or Lead Optimisation candidates (LO), both historic and modern, that are used to further validate a potential drug target.
During this second module we will provide an insight into the challenges of moving a compound from an LO candidate to a pre-clinical candidate. How bio-marker companion tests are developed, validated and are used to underpin clinical trials. The lectures will also provide a keen insight into novel formulation strategies currently under development within Queen’s University Belfast. In addition, we will also provide an insight into the development of bio-therapeutics, such as antibodies, that are proving to be a powerful alternative to small molecule based therapeutics.
For further information email [email protected] or send us a message on WhatsApp
The strong links between us and the biotech and bio-pharmaceutical sectors provides a stimulating translational environment, while also expanding your career opportunities.
GLOBAL OPPORTUNITIES
INDUSTRY LINKS
WORLD CLASS FACILITIES
INTERNATIONALLY RENOWNED EXPERTS
Research Project
Research Translational: from Concept to Commercialisation (Full Year)
Diagnosis and Treatment of Cancer
Cancer Biology
Target Identification and Development in Drug Discovery
Drug optimization, drug delivery and clinical trials
For further information email [email protected] or send us a message on WhatsApp
This is an intensive 11-month full-time programme that combines taught and research components to provide students with state-of-the-art education at the interface of biology with physical sciences and technology. The programme draws on the world-class research and teaching expertise in biotechnology at the University of Cambridge, and it has been designed to respond to major employers' needs and the skills gap in the biotech and pharma sectors. It is based at the Department of Chemical Engineering and Biotechnology, but tightly coupled to other departments within the University, which contribute to teaching and host research projects in the respective areas of expertise in a truly multidisciplinary configuration. The programme also benefits from input from a range of industry champions. Students are given plenty of opportunities to interact with industry experts in order to understand the biotech industry landscape and boost their professional networks.
The programme is aimed at those who want to gain fundamental and advanced understanding of biotechnology as well as the necessary skillset and business acumen to become future leaders in biotechnology either in academic or commercial settings.
The programme has been designed to provide all-round training covering four key areas: core and advanced knowledge, practical skills, research skills, and business-relevant competences. We equip our students with basic and advanced theoretical knowledge in biotechnology, focussing on core areas as well as giving them the opportunity to immerge in one of the world's leading research universities and learn about the latest advances in the field. In addition to theoretical knowledge, we ensure that our students acquire the necessary practical skills in biotechnology both for wet-laboratory and computer-based work. Throughout the programme, significant emphasis is put on the development of research skills, including critical thinking, documenting and reporting, academic writing and communication, and research management. The fast-paced, demanding and competitive environment in which biotechnology research and commercialisation takes place calls for business-savvy scientists, be it in academia or industry. Our programme offers a range of opportunities for students to acquire business-relevant knowledge and skills.
Our students are prepared to pursue a career in the pharmaceutical, healthcare, agritech, or bioenergy industries, or in other sectors where bioprocesses are important. The programme may also be a stepping stone to PhD level studies. The programme’s structure and content are flexible so that the students can tailor their studies to their interests and career goals.
Our students have access to the University’s exceptional Careers Service. It provides general career planning advice, organises recruitment events that attract major global companies and high-profile employers, and offers one-to-one sessions with its careers advisers. The programme's staff and industry champions are also available to provide advice in their area of specialisation. University-wide events (e.g. extra-curricular entrepreneurship activities) and the fact that Cambridge is home to one of the most important biotech clusters in Europe create great networking and career development opportunities.
The University of Cambridge is well known by the talent pool it generates, and its graduates are amongst the world’s most sought-after by employers.
https://www.ceb.cam.ac.uk/postgraduates-tab/mphil-biotechnology/applying
Our Pharmaceutical Technology MSc offers you world-class teaching in formulation and drug delivery from internationally renowned scientists. This course has a strong scientific base, designed specifically to improve the skills of pharmacists and graduates with life sciences, chemistry and chemical engineering backgrounds. You will gain hands-on practical experience with some of the most advanced techniques and instruments, and conduct research with experts in the field.
This course will teach you about the science and application of the formulation of pharmaceutical products, and will allow you to assist in the discovery and development of better medicines.
We aim to give you the knowledge and expertise in liquid and solid dosage form design and handling which you will need for a career in the pharmaceutical industry, research institutes or biotech. You will also gain an understanding of the scientific principles that underpin dosage form stability. You will undertake in-depth study and research into the biopharmaceutic and physicochemical aspects of dosage form design.
Teaching
You will be taught by academic staff who are experts in the field and who are members of an internationally leading team. Your contact time will be as follows:
Typically, one credit equates to 10 hours of work
Assessment
We will assess you through a combination of exams, essays and coursework .
The study time and assessment methods detailed above are typical and give you a good indication of what to expect. However, they may change if the course modules change.
Recent graduates have gone on to take PhD studies; to work in R&D laboratories in the pharmaceutical industry; or biotech. Overseas students have returned to similar positions in their home countries.
This MSc will provide students with the skills and knowledge to allow them to participate effectively in the creation and growth of high-impact pharmaceutical business ventures. Its graduates will be ideally positioned to initiate their own start-up companies or join existing biotech or pharmaceutical businesses.
Students will learn how to develop and assess a new business concept, and how to raise finance for and market a business and its outputs. They will build their scientific skill set by exploring four scientific research areas in pharmaceutics, and will interact closely with and be mentored by those who have direct experience of initiating a start-up business.
Students undertake modules to the value of 180 credits.
The programme consists of four core modules (60 credits), four optional modules (60 credits), a scientific research project (30 credits) and a business case development project (30 credits).
Core modules
Optional modules
Students select three optional modules in term one (from a choice of four), and a further optional module (from a choice of five) in term two.
Dissertation/report
Students undertake two projects which culminate in two written reports and oral presentations. One is a short laboratory research project, while the second involves the development of a business case for a new pharmaceutical endeavour.
Teaching and learning
The programme is delivered through a combination of lectures, tutorials, seminars and practical sessions, as well as industrial visits. Assessment is through a combination of written examinations, coursework assignments and project work.
Further information on modules and degree structure is available on the department website: Pharmaceutical Formulation and Entrepreneurship MSc
For a comprehensive list of the funding opportunities available at UCL, including funding relevant to your nationality, please visit the Scholarships and Funding website.
Graduates from this MSc find work in various areas of the pharmaceutical and biotechnology industries. They are fully equipped with the skills to start their own businesses, and can approach UCL Innovation and Enterprise to assist with this if desired. Alternatively, they may join small biotech or major pharmaceutical companies, pursue further research in academia, work in consulting, or join world-leading technology companies where there is increasing emphasis on healthcare and the life sciences. For instance, recent graduates have undertaken PhD research at the University of Cambridge or found work with start-ups such as Intract Pharma.
Employability
Employability skills are embedded in the programme, with emphasis placed on the development of "soft" skills and a series of workshop sessions organised on CV writing, undertaking interviews, and networking. We make extensive efforts to provide opportunities for students to meet with potential employers. Students from this MSc are highly competitive in the global jobs market.
This programme is unique in equipping students with a broad skill set in both medicines design and entrepreneurship. It is delivered by world-leading academics in both the UCL School of Pharmacy and UCL School of Management.
UCL staff with direct experience of launching a pharmaceutical start-up will teach students best practice and how to overcome the major challenges involved in enterprises of this kind.
UCL’s central London location combines state-of-the-art research with an entrepreneurial dynamic that fosters start-up creation, and provides access to venture capitalists, business angels, and world-leading pharmaceutical companies. UCL Innovation and Enterprise, UCL’s centre for entrepreneurship and business interaction, offers UCL students direct practical support in launching a business.
This programme is offered by the UCL Division of Medicine and the Wolfson Institute for Biomedical Research and is designed for the more research-oriented student, complementing the Drug Design MSc. Conducting cutting-edge research within the drug industries and UCL's academic group, it offers opportunities for networking and future career development.
This programme teaches students the latest methodologies and approaches and covers all aspects of drug design: drug discovery, computational and structural biology, screening, assay development, medicinal chemistry, and most importantly the industrial practices involved in modern drug design technology.
Students undertake modules to the value of 180 credits.
The programme consists of one core modules (15 credits), four optional modules (60 credits) and a dissertation/report (105 credits).
Core module
Optional modules
Students select four of the following.
Dissertation/report
All students undertake an independent research project which culminates in a dissertation of 15,000 to 20,000 words.
Teaching and learning
The programme is delivered through a combination of lectures, seminars, tutorials and problem classes, critical journal clubs and a research project. Assessment is through coursework, practicals, laboratory work, examination, dissertation and oral presentation.
Further information on modules and degree structure is available on the department website: Drug Design MRes
We expect students graduating from this programme to take leading roles in drug discovery and development worldwide or to undertake further PhD-level research. Drug Design MRes graduates have found jobs in the pharmaceutical industry as well as PhD studentships in leading universities
Employability
The advanced knowledge and skill set acquired by taking this programme will enable students to find employment in the pharmaceutical and biotech industries in a global market.
The division hosts research groups in the areas of medicine, pharmaceutical research, cell cycle, neurobiology, mitochondrial function, stem cells and cancer. Underpinning the translational aspects of the biomedical research, we have a medicinal chemistry group which conducts research where chemistry and biology intersect, using the latest techniques and developing new ones for the study of biological systems.
The division collaborates extensively within industry and academia to develop biological tools and therapeutic agents. There are plenty of opportunities to conduct translational research that has an impact on drug discovery.
Pharmaceutical and biotech companies, well established in the West, have been transferring their research and development to the East. Given these substantial developments, particularly in China and India, the programme will have a broad international appeal.
The Research Excellence Framework, or REF, is the system for assessing the quality of research in UK higher education institutions. The 2014 REF was carried out by the UK's higher education funding bodies, and the results used to allocate research funding from 2015/16.
The following REF score was awarded to the department: Division of Medicine
80% rated 4* (‘world-leading’) or 3* (‘internationally excellent’)
Learn more about the scope of UCL's research, and browse case studies, on our Research Impact website.
This study course is for students who wish to become specialised graduates with an advanced biomedical knowledge concerning the links between the structure and the purpose of biomolecules and bio-systems operating at cellular and tissue level of the human body, in both physiological and pathological conditions. The wide knowledge of the techniques is based on a solid practical activity in laboratories during the internship.
Subject to the educational aims of Class LM-9, the acquired knowledge allows specialized graduates to assist physicians in the diagnostic and therapeutic tasks involving the manipulation of cells, genes, and other biosystems requiring applicants to learn special skills in experimental biotechnology (e.g. Diagnosis and gene therapy; therapy through the use of genetically engineered cells; rational design and development of new medicines based on models of molecular targets known or derived from pharmacogenomic knowledge; preparation of nano-biotechnological tools for advanced diagnostics imaging and drug delivery; modulation of the immune response; diagnostics based on innovative processes of science and medical laboratory techniques; immunotherapy to targeted cells); organize and coordinate laboratory activities for advanced research or for diagnostic examinations requiring the use of biotechnological methods and the manipulation of cells or biotechnological materials; organize and coordinate the experimental protocols of clinical research involving the use of materials or biotechnology techniques; design and perform with autonomy research in biotechnology applied to medicine; lead and coordinate, also in governance, development programs and surveillance of biotechnology applied to human beings, taking into account the ethical, technical, environmental and economic implications.
First year: Advanced Biomedical Technologies Or Laboratory Activities 1: Cellular And Molecular Therapies Or Laboratory Activities 2: Molecular And Systems Biology, Laboratory Medicine Technologies And Molecular Diagnostics, Pharmaceutical Biotechnology: Design And Analysis Of Biopharmaceuticals, Seminar
Molecular Medicine Curriculum: 6 Months At Ulm University: Glp/Gsp Bioethics, Molecular Oncology, Trauma Research And Regenerative Medicine
Traditional Curriculum: Proteomics And Bioinformatics, Cell And Organ Physiology And Medical Pathophysiology, Genetics, Immunology And General Pathology, Nanobiotechnology
Second year: Experimental Models In Vivo And Vitro, Pharmacology And Molecular Therapies, Stem Cell Biology And Molecular Biology Of Development, Thesis Work
Molecular Medicine Curriculum + Proteomics And Bioinformatics
Biotechnology physicians will be able to head research laboratories in a predominantly technological and pharmacological environment and coordinate, as well as in terms of management and administration, program development and the monitoring of biotechnology applied on human beings with emphasis on the development of pharmaceutical products and vaccines, taking into account the ethical, technical, and legal implications and environmental protection.
Graduates will be able to assist doctors in the diagnostic and in the therapeutic phases when those imply the manipulation of cells, genes and other bio systems and when specific biotechnological experimental competences are required.
The University of Padova, the Veneto Region and other organisations offer various scholarship schemes to support students. Below is a list of the funding opportunities that are most often used by international students in Padova.
You can find more information below and on our website here: http://www.unipd.it/en/studying-padova/funding-and-fees/scholarships
You can find more information on fee waivers here: http://www.unipd.it/en/fee-waivers
The MSc in Cancer Medicine will provide students with new knowledge of how precision medicine can improve and shape future healthcare. Students will gain hands-on experience of molecular techniques and the equipment/devices used in a modern molecular laboratory; the course will provide training in laboratory and research skills that are applicable across multiple scientific disciplines in a supportive learning environment. Students will be able to evaluate how novel therapeutic approaches can be used to stratify patients into treatment groups for better clinical management (stratified / precision medicine). They will observe the delivery of precision medicine through tours of the Northern Ireland Cancer Centre.
There are optional modules in the second semester allowing students to explore.the fundamental principles of Carcinogenesis and the translational approaches (including cutting edge technologies) which allow cancer scientists and clinicians to advance our understanding and treatment of cancers. The Precision Cancer Medicine stream provides a comprehensive overview of the current understanding of the Hallmarks of Cancer from the role of genetic/epigenetic alterations, cell cycle control and metastases/angiogenesis to the development of applications to help diagnose cancers earlier, improve treatments, rationally design clinical trials and reduce chemotherapy drug resistance.
The Radiation Oncology stream will develop skills in understanding the biological principles of radiotherapy and its clinical applications in the treatment of cancer. This will include the physical and chemical basis of radiation interactions and the biological consequences of radiation exposures. Clinical aspects of Radiation Oncology will be covered including principle of advanced radiotherapy delivery, cancer imaging techniques and biomarker discovery.
Importantly, both streams show how our improved understanding of the molecular processes driving cancer growth and spread can be ‘translated’ through research-intensive MSc projects to improve the treatment and survival of cancer patients.
For further information email [email protected] or send us a message on WhatsApp
The strong links between us and the biotech and biopharmaceutical sectors provides a stimulating translational environment, while also expanding your career opportunities.
GLOBAL OPPORTUNITIES
INDUSTRY LINKS
WORLD CLASS FACILITIES
INTERNATIONALLY RENOWNED EXPERTS
Semester 1
Research Translational: from Concept to Commercialisation (Full Year)
Diagnosis and Treatment (Semester 1)
Cancer Biology (Semester 1)
Students will make a selection from the following modules:
OR
Clinical Radiation
Building on the biological basis of radiotherapy, this module will develop knowledge and skills in understanding clinical radiotherapy and medical imaging. Through the delivery of a multidisciplinary taught programme, students will cover clinical tumour and normal tissue biology, radiological imaging and the design of radiotherapy treatment plans. This will develop the clinical rationale for radiotherapy in the treatment of cancer and highlight emerging treatment combinations and techniques for biomarker discovery in radiation oncology.Biology and Imaging
Research Project
You will undertake a project in the Centre for Cancer Research and Cell Biology.
Dissertation
This module comprises the write-up contribution to the overall research element of the programme, with the Research Project (SCM 8067). The Dissertation will represent the student’s personal studies in the literature, a description of their experimental execution of their project, data presentation, analysis and interpretation, followed by critical discussion and conclusions.
For further information email [email protected] or send us a message on WhatsApp
Lead academic: Dr Martin Nicklin
This flexible course focuses on the molecular and genetic factors of human diseases. Understanding those factors is crucial to the development of therapies.
Core modules cover the fundamentals. You choose specialist modules from the pathway that interests you most.
We also give you practical lab training to prepare you for your research project. The project is five months of invaluable laboratory experience: planning, carrying out, recording and reporting your own research.
Recent graduates work in academic research science, pharmaceuticals and the biotech industry.
You’ll be based in teaching hospitals that serve a population of over half a million people and refer a further two million. We also have close links with the University’s other health-related departments.
Our research funding comes from many sources including the NIHR, MRC, BBSRC, EPSRC, the Department of Health, EU, and prominent charities such as the Wellcome Trust, ARC, YCR, Cancer Research UK and BHF. Our partners and sponsors include Novartis, GlaxoSmithKline, Pfizer, Astra Zeneca and Eli Lilly.
You’ll also benefit from our collaboration with the Department of Biomedical Sciences.
Classes are kept small (15–20 students) to make sure you get the best possible experience in laboratories and in clinical settings.
We have a state-of-the-art biorepository and a £30m stem cell laboratory. The Sheffield Institute of Translational Neuroscience (SITraN) opened in November 2010. We also have microarray, genetics, histology, flow cytometry and high-throughput screening technology, and the latest equipment for bone and oncology research.
At our Clinical Research Facility, you’ll be able to conduct studies with adult patients and volunteers. The Sheffield Children’s Hospital houses a complementary facility for paediatric experimental medical research.
If your course involves a significant risk of exposure to human blood or other body fluids and tissue, you’ll need to complete a course of Hepatitis B immunisation before starting. We conform to national guidelines that are in place to protect patients, health care workers and students.
Genetic Mechanisms pathway
Microbes and Infection pathway
Experimental Medicine pathway
Cancer pathway
Cardiovascular pathway
Clinical Applications pathway
Apply directly to this pathway. Available only to medical graduates. Students are recruited to a specialist clinical team and pursue the taught programme (1-5) related to the attachment. They are then attached to a clinical team for 20 weeks, either for a clinical research project or for clinical observations. See website for more detail and current attachments.
Lectures, seminars, tutorials, laboratory demonstrations, computer practicals and student presentations.
Assessment is continuous. Most modules are assessed by written assignments and coursework, although there are some written exams.
Two modules are assessed by verbal presentations.
Your research project is assessed by a thesis, possibly with a viva.
The Drug Discovery Skills MSc course aims to equip you with the advanced skills to enhance your knowledge and technical expertise in the drug discovery process.
The Drug Discovery Skills MSc is a one-year advanced course that runs from September to September and you will study modules totalling 180 credits throughout the year, with 75 credits coming from the research project and a dissertation to complete the programme.
You will study a range of modules that include core skills and case histories in drug discovery. You will also complete an extended industry-based research project and dissertation relating to drug discovery.
On average teaching consists of:
Typically, one credit equates to 10 hours of work.
Assessment
The study time and assessment methods detailed above are typical and give you a good indication of what to expect.
Location
This course is primarily taught at the King’s College London Guy’s campus. The work placement for the Research Project in Drug Discovery is usually in the UK laboratories of a pharmaceutical or biotech company.
Our graduates mainly gain employment in the pharmaceutical industry, or go on to study for a PhD.
